TCL Archive In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine November 23, 1979
TCL Archive White House Defers to Pressure, Gives Up Attempt to Cut NIH Budget $334 Million In ‘87 March 6, 1987
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Also STAR trial can be completed with fewer women than planned, NSABP says. November 7, 2003
